Please enable JS

ARTICLES & TESTIMONIALS

Mississippi Patient Access Joint Letter

Jul 08/50SN Staff/ Open Comments

Dear Mississippi Legislator: Almost all consumers who have health insurance pay only a portion of the cost for prescription medications. Most health insurance providers contract with third-party companies called pharmacy benefit managers (PBMs) to administer and process prescription drug claims. PBMs and insurersset the out-of-pocket price a consumer must pay for medicine, a practice sometimes […]

READ MORE

South Carolina 1115 Mediciad Waiver

Jul 08/50SN Staff/ Open Comments

January 22, 2019 Joshua D. BakerDirectorSouth Carolina Department of Health and Human ServicesP.O. Box 8206Columbia, SC 29202Re: South Carolina 1115 Demonstration Waiver Application –South Carolina Medicaid Community EngagementSubmitted via EmailDear Mr. Baker: The Global Healthy Living Foundation (GHLF) appreciates the opportunity to submit comments on the South Carolina 1115 Demonstration Waiver Application –South Carolina Medicaid […]

READ MORE

Healthy People 2030

Jul 08/50SN Staff/ Open Comments

January 17th,2019 Alex Azar, JD Secretary, U.S.Department of Health and Human Services 330 C Street SWWashington, DC 20416Re: Public Comment for Healthy People 2030Comments submitted via emailto [email protected] Secretary Azar, The Global Healthy Living Foundation (GHLF) appreciates the opportunity to provide comments for Healthy People 2030. GHLF is a 20-year-old 501(c)(3) patient organization representing chronically […]

READ MORE

Advertising campaign led by ACS-CAN

Jul 08/50SN Staff/ Open Comments

Advertising ACS CAN plans to do starting January 17th on the proposed policy changes to Medicare Part D’s “Six Protected Classes”. I originally sent an email before the holidays about the advertising opportunity, and then emailed some groups again last Friday. Unfortunately my email last Friday was not sent to our entire partner list.

READ MORE

Patients’ Perspectives on Romosozumab

Jul 08/50SN Staff/ Open Comments

Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee Meeting; Public Hearing. Docket No. FDA-2018-N-4116 Oral Comments made by patient Judith Marple on behalf of the Global Healthy Living Foundation “Patients’ Perspectives on Romosozumab” January 16th, 2019 Disclosure: I have disclosures to make. The Global Healthy Living Foundation paid for my travel here today. […]

READ MORE